Larkin Cristina 4
4 · Spero Therapeutics, Inc. · Filed Nov 7, 2017
Insider Transaction Report
Form 4
Larkin Cristina
Chief Operating Officer
Transactions
- Purchase
Common Stock
2017-11-06$14.00/sh+1,500$21,000→ 1,500 total
Footnotes (1)
- [F1]Reflects shares that were purchased through a directed share program in connection with the Issuer's initial public offering.